Antiseptics and Disinfectant Market

TABLE OF CONTENTS

1 INTRODUCTION
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
    2.1 RESEARCH DATA
    2.2 RESEARCH APPROACH
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Key industry insights
    2.3 MARKET SIZE ESTIMATION
           2.3.1 BOTTOM-UP APPROACH
           2.3.2 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 GROWTH RATE ASSUMPTIONS
    2.7 LIMITATIONS
    2.8 RISK ASSESSMENT
    2.9 COVID-19 HEALTH ASSESSMENT
    2.10 COVID-19 ECONOMIC ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Rising demand for infection control measures to curb the occurrence of hospital acquired infections
                    5.2.1.2 Growing awareness of sanitization and hygiene due spread of infectious diseases like COVID-19
                    5.2.1.3 The increasing number of surgical procedures across the globe
                    5.2.1.3 Increase in R&D expenditure
           5.2.2 RESTRAINTS
                    5.2.2.1 Increasing development of alternative technologies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing healthcare expenditure and focus in emerging countries
           5.2.4 CHALLENGES
                    5.2.4.1 Rising number of adverse effects of chemical antiseptics and disinfectants
    5.4 PRICING ANALYSIS
    5.5 PATENT ANALYSIS
    5.6 TRADE ANALYSIS
    5.7 VALUE CHAIN ANALYSIS
    5.8 SUPPLY CHAIN ANALYSIS
    5.9 ECOSYSTEM ANALYSIS OF ANTISEPTICS AND DISINFECTANTS MARKET
    5.10 PORTER’S FIVE FORCES ANALYSIS
    5.11 PESTLE ANALYSIS
    5.12 REGULATORY LANDSCAPE
    5.13 TECHNOLOGY ANALYSIS
    5.14 DISRUPTIVE TECHNOLOGIES IN ANTISEPTICS AND DISINFECTANTS MARKET

6 GLOBAL ANTISEPTICS AND DISINFECTANTS MARKET, BY TYPE (USD MILLION)
    6.1 INTRODUCTION
    6.2 QUATERNARY AMMONIUM COMPOUNDS
    6.3 CHLORINE COMPOUNDS
    6.4 ALCOHOL / ALDEHYDE PRODUCTS
    6.5 ENZYME 
    6.6 OTHER ANTISEPTICS AND DISINFECTANTS

7 GLOBAL ANTISEPTICS AND DISINFECTANTS MARKET, BY PRODUCT (USD MILLIONS)
    7.1 INTRODUCTION
    7.2 ENZYMATIC CLEANERS
    7.3 MEDICAL DEVICE DISINFECTATS
    7.4 SURFACE DISINFECTANTS

8 GLOBAL ANTISEPTICS AND DISINFECTANTS MARKET, BY SALES CHANNEL
    8.1 INTRODUCTION
    8.2 FMCG
    8.3 B2B

9 GLOBAL ANTISEPTICS AND DISINFECTANTS MARKET, BY END USER
    9.1 INTRODUCTION
    9.2 HOSPITALS
    9.3 CLINICS
    9.4 OTHERS

10 GLOBAL ANTISEPTICS AND DISINFECTANTS MARKET, BY REGION
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
             10.2.2 CANADA
     10.3 EUROPE
             10.3.1 GERMANY
             10.3.2 UK
             10.3.3 FRANCE
             10.3.4 ITALY
             10.3.5 SPAIN
             10.3.6 REST OF EUROPE
     10.4 ASIA PACIFIC
             10.4.1 CHINA
             10.4.2 JAPAN
             10.4.3 INDIA
             10.4.4 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
     11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
     11.4 MARKET SHARE ANALYSIS
     11.5 COMPANY EVALUATION QUADRANT
     11.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2020)
     11.7 COMPETITIVE BENCHMARKING
     11.8 COMPETITIVE SCENARIO

12 COMPANY PROFILES
     12.1 KEY PLAYERS
(Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) *
             12.1.1 3M
             12.1.2 RECKITT BENCKISER
             12.1.3 STERIS PLC
             12.1.4 KINBERLY CLARK CORPORATION
             12.1.5 BIO-CIDE INTERNATIONAL
             12.1.6 CARDINAL HEALTH
             12.1.7 BECTON DICKINSON AND COMPANY
             12.1.8 JOHNSON & JOHNSON
             12.1.9 PAUL HARTMANN AG
             12.1.10 CANTEL MEDICAL CORPORATION

*Details on Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats might not be captured in case of unlisted companies.

13 APPENDIX
     13.1 INDUSTRY INSIGHTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS